Research programme: opioid mu receptor agonists/delta receptor antagonists - Johnson & JohnsonAlternative Names: Mu agonist/delta antagonist - Johnson & Johnson
Latest Information Update: 19 Mar 2014
At a glance
- Originator Johnson & Johnson
- Mechanism of Action Opioid delta receptor antagonists; Opioid mu receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Irritable bowel syndrome
Most Recent Events
- 19 Mar 2014 Discontinued - Preclinical for Irritable bowel syndrome in USA (unspecified route)